Immuneering Corp. (IMRX)
5.02
+0.16
(+3.29%)
USD |
NASDAQ |
Mar 20, 16:00
5.05
+0.03
(+0.60%)
After-Hours: 20:00
Immuneering Total Liabilities (Quarterly) : 13.50M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 161.76M |
| Verastem, Inc. | 189.24M |
| Phathom Pharmaceuticals, Inc. | 697.97M |
| Tango Therapeutics, Inc. | 63.83M |
| X4 Pharmaceuticals, Inc. | 104.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 231.98M |
| Shareholders Equity (Quarterly) | 218.48M |
| Debt to Equity Ratio | 0.0175 |
| Current Ratio | 17.50 |
| Net Debt Paydown Yield | 0.02% |